Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer

Understanding the cellular origins and early evolutionary dynamics that drive the initiation of carcinogenesis is critical to advancing early detection and prevention strategies. By characterizing key molecular, cellular and niche events at the precancerous tipping point of early gastric cancer (EGC), we aimed to develop more precise screening tools and design targeted interventions to prevent malignant transformation at this stage. We utilized our AI models to integrate spatial multimodal data from nine EGC endoscopic submucosal dissection (ESD) samples (covering sequential stages from normal to cancer), construct a spatial-temporal profile of disease progression, and identify a critical tipping point (PMC_P) characterized by an immune-suppressive microenvironment during early cancer development. At this stage, inflammatory pit mucous cells with stemness (PMC_2) interact with fibroblasts via NAMPT <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>⟶</mml:mo></mml:math> ITGA5/ITGB1 and with macrophages via AREG <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>⟶</mml:mo></mml:math> EGFR/ERBB2 signaling, fostering cancer initiation. We established gastric precancerous cell lines and organoids to demonstrate that NAMPT and AREG promote cellular proliferation in vitro. Furthermore, in the transgenic CEA-SV40 mouse model, targeting AREG and/or NAMPT disrupted key cell interactions, inhibited the JAK-STAT, MAPK, and NFκB pathways, and reduced PD-L1 expression, which was also confirmed by western blot in vitro. These interventions delayed disease progression, reversed the immunosuppressive microenvironment, and prevented malignant transformation. Clinical validation was conducted using endoscopically resected EGC specimens. Our study provides a precise spatiotemporal depiction of EGC development and identifies novel diagnostic markers and therapeutic targets for early intervention.

Authors

Institutions

Publication Details

Journal
Signal Transduction and Targeted Therapy
Published
2025-09-21
DOI
https://doi.org/10.1038/s41392-025-02390-w
Citations
6
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
4.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer

Ruijie Gong, Wei Su, Shengli Lin, Wei Yuan et al.
6 citations
Signal Transduction and Targeted Therapy
Immune cells in cancer
4.78
article

Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer

Ruijie Gong, Wei Su, Shengli Lin, Wei Yuan, Xiaoqiang Chai, Jiabin Cai, Quan‐Lin Li, Ming‐Yan Cai, Yun Wang, Jia Yu, Chunman Zuo, Zuqiang Liu, Lili Ma, Ping‐Hong Zhou, Pingting Gao, Lu Yao
article en
6 citations

Abstract

Understanding the cellular origins and early evolutionary dynamics that drive the initiation of carcinogenesis is critical to advancing early detection and prevention strategies. By characterizing key molecular, cellular and niche events at the precancerous tipping point of early gastric cancer (EGC), we aimed to develop more precise screening tools and design targeted interventions to prevent malignant transformation at this stage. We utilized our AI models to integrate spatial multimodal data from nine EGC endoscopic submucosal dissection (ESD) samples (covering sequential stages from normal to cancer), construct a spatial-temporal profile of disease progression, and identify a critical tipping point (PMC_P) characterized by an immune-suppressive microenvironment during early cancer development. At this stage, inflammatory pit mucous cells with stemness (PMC_2) interact with fibroblasts via NAMPT <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>⟶</mml:mo></mml:math> ITGA5/ITGB1 and with macrophages via AREG <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>⟶</mml:mo></mml:math> EGFR/ERBB2 signaling, fostering cancer initiation. We established gastric precancerous cell lines and organoids to demonstrate that NAMPT and AREG promote cellular proliferation in vitro. Furthermore, in the transgenic CEA-SV40 mouse model, targeting AREG and/or NAMPT disrupted key cell interactions, inhibited the JAK-STAT, MAPK, and NFκB pathways, and reduced PD-L1 expression, which was also confirmed by western blot in vitro. These interventions delayed disease progression, reversed the immunosuppressive microenvironment, and prevented malignant transformation. Clinical validation was conducted using endoscopically resected EGC specimens. Our study provides a precise spatiotemporal depiction of EGC development and identifies novel diagnostic markers and therapeutic targets for early intervention.

Signal Transduction and Targeted TherapyVol. 10(1)
Sun Yat-sen University (CN), Fudan University (CN), Zhongshan Hospital (CN), Ministry of Education (ET)
Openalex Percentile: Top 4%
Immune cells in cancer
4.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.